AD+ Think Tank

The 2026 AD+ Think Tank meeting took place in Gainesville, FL on January 27-28, 2026.

2026 AD+ Think Tank

As we begin planning for next year, we would truly value your feedback. Please consider taking a few minutes to complete our brief post-event survey so we can continue to strengthen and improve the Think Tank experience:

Wednesday, January 28, 2026


Registration & Breakfast: 7:00am – 8:00am


8:00am – 10:00am

Session 1

Moderator: Matt LaVoie, Ph.D.

The Feinstein Institutes for Medical Research

David Eidelberg, M.D.

“Novel classification of neurodegenerative disorders based on metabolic imaging of the default mode network”

David Eidelberg Headshot

University of Florida

Catherine Price, Ph.D., ABPP-cn

“Neuroimaging Brain Burden and AD+ in the Perioperative Setting: Why and How To”

Catherine Price, Ph.D., ABPP

University of Pennsylvania

David Irwin, M.D.

“Integrating histology and imaging data for tissue-sensitive biomarker development in ADRD”

Irwin Headshot

Break: 10:00am – 10:30am


10:30am – 12:30pm

Session 2

Moderator: Breton Asken, Ph.D., ATC

Johns Hopkins University

Arnold Bakker, Ph.D.

“Imaging the path forward in Alzheimer’s Disease”

Arnold Bakker

Stanford University

Kathleen Poston, M.D., MS

“Mixed Pathologies and Biological Staging in Neurodegenerative Diseases of Aging”

Kathleen Poston Headshot

The University of alabama at birmingham

Vriendra Mishra, Ph.D.

“Understanding Cognitive Decline in Individuals with Parkinson’s Disease through Various MRI-based Measures”

Vriendra Mishra

Group Photo, Lunch & Networking: 12:30pm – 2:00pm


2:00pm – 4:00pm

Session 3

Moderator: Stefan Prokop, M.D.

University of Florida

David Vaillancourt, Ph.D.

“Automated Imaging Differentiation for Parkinsonism (AIDP) and Dementia (AIDD)”

Vaillancourt

Johns Hopkins university

Kelly Mills, M.D.

“Exploring Cognition and CNS Neuroinflammation in neurodegeneration with PET”

Kelly Mills Headshot

University of miami

Rosie Curiel, Psy.D.

“Plasma Biomarkers and Novel Brief Cognitive Screening Tests for Alzheimer’s Detection: Promise, Precision, and the Impact of Systemic Health Conditions”

Rosie Curiel

Adjourn and Depart: 4:00pm